Newsletter
28 de October de 2014
Newsletter 2014.07 – ANVISA publishes resolutions on new procedures relative to marketing authorization in Brazil: RDC #58 and #60/2014
The main law regulating the health system in Brazil – Law #6,360 dated 1976 – establishes that each and every drug available in the pharmaceutical market must be approved by the Ministry of Health. Since the creation of the Brazilian FDA (called ANVISA), this autonomous autarchy subordinated to the Ministry of Health is in charge of issuing marketing authorization for drugs for human use and of establishing specific resolutions in order to regulate each of the existing categories of medicaments, such as the new drugs, generics, similars, biologicals.
According to ANVISA’s requirements, the documentation submitted by the manufacturers of both generic and similar drugs, upon applying for marketing approval, is significantly simplified compared to the reference product (the so-called “abridged process”), as only pharmaceutical equivalence and relative bioavailability/ bioequivalence assays are required to obtain approval for products pertaining to these categories.
It should be noted that, since the publication of Resolutions RDC #133 (new applications for marketing approval) and RDC #134 (similars, already approved), both dated May 29, 2003, ANVISA has begun to require proof of therapeutic equivalence also for similar drugs; therefore, it is estimated that all manufacturers of these products will have complied with such requirement by the end of 2014.
Accordingly, studies of pharmaceutical equivalence and bioavailability/bioequivalence became necessary in order to obtain marketing authorization for both generic and similar drugs, although the latter were not then yet considered to be interchangeable with the reference product.
Last related news
24 de July de 2025
Countdown: 30 days to comply with Brazilian Rules about International Data Transfer
On August 23, 2024, the Brazilian Data Protection Authority (“ANPD”) published the Resolution CD/ANPD No. 19/2024, which approved the regulation on international … Countdown: 30 days to comply with Brazilian Rules about International Data Transfer
22 de July de 2025
Intellectual property in the workplace: real risks for companies and employees
Respect for intellectual property rights, especially regarding the use of licensed software, is a critical obligation in today’s corporate environment. Installing or … Intellectual property in the workplace: real risks for companies and employees
9 de July de 2025
Tracking and Telemetry in the Fight Against Software Piracy: An Analysis Under the LGPD and GDPR
The use of telemetry and tracking technologies by software developers to detect and combat the unauthorized use of their products has become … Tracking and Telemetry in the Fight Against Software Piracy: An Analysis Under the LGPD and GDPR